SYNULOX PALATABLE TABLETS 250 MG
Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Характеристики продукта
(SPC)
28-01-2015
Деякі документи на цей товар наразі недоступні. Ви можете надіслати запит до нашої служби підтримки, і ми повідомимо вас, як тільки ми зможемо їх отримати.
Відправляти запит.
Відправляти запит.
Активний інгредієнт:
AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM
Доступна з:
Zoetis Ireland Limited
Код атс:
QJ01CR02
ІПН (Міжнародна Ім'я):
AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM
Дозування:
200
Фармацевтична форма:
Tablets
Тип рецепту:
POM
Терапевтична група:
Canine, Feline
Терапевтична области:
Amoxicillin and enzyme inhibitor
Терапевтичні свідчення:
Antibacterial
Статус Авторизація:
Authorised
Дата Авторизація:
2015-01-09
Характеристики продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Synulox Palatable Tablets 250 mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Tablet.
Speckled pink flat circular tablets with bevelled edges.
The tablet has a break line on one face and “SYNULOX” engraved on the other.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Clinically Synulox has been shown to be effective in treating a wide range of diseases of cats and dogs including: Skin
disease (including deep and superficial pyodermas); soft tissue infections (abscesses and anal sacculitis); dental
infections (eg gingivitis); urinary tract infections; respiratory disease (involving upper and lower respiratory tract);
enteritis.
4.3 CONTRAINDICATIONS
Synulox Palatable Tablets should not be given to rabbits, guinea pigs, hamsters or gerbils.
Caution is advised in their use in any other very small herbivores.
Synulox is not indicated for cases involving _Pseudomonas _spp.
Do not use in animals with known hypersensitivity to the active ingredients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each tablet contains:
Active ingredients
Amoxicillin (as trihydrate)
200.0 mg
Clavulanic acid (as Potassium clavulanate) 50.0 mg
For a full list of excipients see section 6.1.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 13/01/2015_
_CRN 7019910_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection inhalation
Прочитайте повний документ
